Skip to main content
Erschienen in: Inflammation Research 3/2011

01.03.2011 | Original Research Paper

The modulatory effect of lipids and glucose on the neonatal immune response induced by Staphylococcus epidermidis

verfasst von: Berit Haase, Kirstin Faust, Mathias Heidemann, Tasja Scholz, Martin Demmert, Birte Tröger, Alexander Herz, Christoph Härtel

Erschienen in: Inflammation Research | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Parenteral nutrition is an important risk factor for late onset sepsis in neonates. This may be caused by the long-term need of central venous access but also through a potentially modulating effect of lipids and glucose on the immune function.

Objective

It was the aim of this study to characterize the effect of lipids and glucose on the neonatal immune response in an in vitro Staphylococcus epidermidis sepsis model using whole cord blood of healthy term infants and preterm infants.

Results

At the single cell level, IL-6, IL-8 and TNF-α expression of CD14+ cells was significantly increased upon addition of 1% lipids, while the addition of clinically meaningful lipid concentrations had no remarkable effect. When glucose was added to whole cord blood cultures, a dose-dependent effect was demonstrated for IL-8 expression but not for other cytokines.

Conclusions

These in vitro data suggest that the pro-inflammatory cytokine response to S. epidermidis may be modulated by lipids and glucose. Further studies are needed to investigate whether these findings are applicable to clinical settings and to evaluate the role of cytokine monitoring in infants receiving long-term parenteral nutrition.
Literatur
1.
Zurück zum Zitat Okada Y, Klein NJ, von Saene HK, Webb G, Holzel H, Pierro A. Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Ann Surg. 2000;231:276–81.CrossRefPubMed Okada Y, Klein NJ, von Saene HK, Webb G, Holzel H, Pierro A. Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Ann Surg. 2000;231:276–81.CrossRefPubMed
2.
Zurück zum Zitat Dinerstein A, Nieto RM, Solana CL, Perez GP, Otheguy GP, Largia AM. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants. J Perinatol. 2006;26:436–42.CrossRefPubMed Dinerstein A, Nieto RM, Solana CL, Perez GP, Otheguy GP, Largia AM. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants. J Perinatol. 2006;26:436–42.CrossRefPubMed
3.
Zurück zum Zitat Bohles H. Indications for lipid infusion in pediatric patients. Klin Padiatr. 1989;201:146–53.CrossRefPubMed Bohles H. Indications for lipid infusion in pediatric patients. Klin Padiatr. 1989;201:146–53.CrossRefPubMed
4.
Zurück zum Zitat Lai NM, Rajadurai SV, Tan KH. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung disease. Cochrane Database Syst Rev 2006; 3: CD005093. Lai NM, Rajadurai SV, Tan KH. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung disease. Cochrane Database Syst Rev 2006; 3: CD005093.
5.
Zurück zum Zitat Wesley JR, Coran AG. Intravenous nutrition for the pediatric patient. Semin Pediatr Surg. 1992;1:212–30.PubMed Wesley JR, Coran AG. Intravenous nutrition for the pediatric patient. Semin Pediatr Surg. 1992;1:212–30.PubMed
6.
Zurück zum Zitat Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol. 2003;27:293–301.CrossRefPubMed Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol. 2003;27:293–301.CrossRefPubMed
7.
Zurück zum Zitat Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–91.CrossRefPubMed Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–91.CrossRefPubMed
8.
Zurück zum Zitat Marchini G, Lindow S, Brismar H, Ståbi B, Berggren V, Ulfgren AK, et al. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol. 2002;147:1127–34.CrossRefPubMed Marchini G, Lindow S, Brismar H, Ståbi B, Berggren V, Ulfgren AK, et al. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol. 2002;147:1127–34.CrossRefPubMed
9.
Zurück zum Zitat Costa SF, Miceli MH, Anaissie EH. Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia. Lancet Infect Dis. 2004;4:278–86.CrossRefPubMed Costa SF, Miceli MH, Anaissie EH. Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia. Lancet Infect Dis. 2004;4:278–86.CrossRefPubMed
10.
Zurück zum Zitat Jarlov JO. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility. APMIS Suppl. 1999;91:1–42.PubMed Jarlov JO. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility. APMIS Suppl. 1999;91:1–42.PubMed
11.
Zurück zum Zitat Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J. 1998;17:10–7.CrossRefPubMed Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J. 1998;17:10–7.CrossRefPubMed
12.
Zurück zum Zitat Sweeney B, Puri B, Reen DJ. Polyunsaturated fatty acids influence neonatal monocyte survival. Pediatr Surg Int. 2001;17:254–8.CrossRefPubMed Sweeney B, Puri B, Reen DJ. Polyunsaturated fatty acids influence neonatal monocyte survival. Pediatr Surg Int. 2001;17:254–8.CrossRefPubMed
13.
Zurück zum Zitat Sweeney B, Puri B, Reen DJ. Modulation of immune cell function by polyunsaturated fatty acids. Pediatr Surg Int. 2005;21:335–40.CrossRefPubMed Sweeney B, Puri B, Reen DJ. Modulation of immune cell function by polyunsaturated fatty acids. Pediatr Surg Int. 2005;21:335–40.CrossRefPubMed
14.
Zurück zum Zitat Yu WK, Li WQ, Li N, Li JS. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003;9:1824–7.PubMed Yu WK, Li WQ, Li N, Li JS. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003;9:1824–7.PubMed
15.
Zurück zum Zitat Monson JR, Ramsden CW, MacFie J, Brennan TG, Guillou PJ. Immunorestorative effect of lipid emulsions during total parenteral nutrition. Br J Surg. 1986;73:843–6.CrossRefPubMed Monson JR, Ramsden CW, MacFie J, Brennan TG, Guillou PJ. Immunorestorative effect of lipid emulsions during total parenteral nutrition. Br J Surg. 1986;73:843–6.CrossRefPubMed
16.
Zurück zum Zitat Sedman PC, Somers SS, Ramsden CW, Brennan TG, Guillou PJ. Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg. 1991;78:1396–9.CrossRefPubMed Sedman PC, Somers SS, Ramsden CW, Brennan TG, Guillou PJ. Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg. 1991;78:1396–9.CrossRefPubMed
17.
Zurück zum Zitat Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359–66.CrossRefPubMed Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359–66.CrossRefPubMed
18.
Zurück zum Zitat Calder PC. Effects of fatty acids and dietary lipids on cells of the immune system. Proc Nutr Soc. 1996;55:127–50.PubMed Calder PC. Effects of fatty acids and dietary lipids on cells of the immune system. Proc Nutr Soc. 1996;55:127–50.PubMed
19.
Zurück zum Zitat Calder PC. N-3 polyunsaturated fatty acids and immune cell function. Adv Enzyme Regul. 1997;37:197–237.CrossRefPubMed Calder PC. N-3 polyunsaturated fatty acids and immune cell function. Adv Enzyme Regul. 1997;37:197–237.CrossRefPubMed
20.
Zurück zum Zitat Hartel C, et al. Characterisation of the host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Arch Dis Child Fetal Neonatal Ed. 2008;93:F140–5.CrossRefPubMed Hartel C, et al. Characterisation of the host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Arch Dis Child Fetal Neonatal Ed. 2008;93:F140–5.CrossRefPubMed
21.
Zurück zum Zitat Janeway CA. Immunobiology. 6th ed. New York: Taylor & Francis Group; 2005:76. Janeway CA. Immunobiology. 6th ed. New York: Taylor & Francis Group; 2005:76.
22.
Zurück zum Zitat Bjorkqvist M, et al. Phenotypic and genotypic characterisation of blood isolates of coagulase-negative staphylococci in the newborn. APMIS. 2002;110(4):332–9.CrossRefPubMed Bjorkqvist M, et al. Phenotypic and genotypic characterisation of blood isolates of coagulase-negative staphylococci in the newborn. APMIS. 2002;110(4):332–9.CrossRefPubMed
23.
Zurück zum Zitat Härtel C, Osthues I, Rupp J, Haase B, Röder K, Göpel W, et al. Does the enteral feeding advancement affect short-term outcomes in very low birth weight infants? J Pediatr Gastroenterol Nutr. 2009;48:464–70.CrossRefPubMed Härtel C, Osthues I, Rupp J, Haase B, Röder K, Göpel W, et al. Does the enteral feeding advancement affect short-term outcomes in very low birth weight infants? J Pediatr Gastroenterol Nutr. 2009;48:464–70.CrossRefPubMed
24.
Zurück zum Zitat Sweeney B, Puri B, Reen DJ. Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. J Pediatr Surg. 2007;42:620–8.CrossRefPubMed Sweeney B, Puri B, Reen DJ. Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. J Pediatr Surg. 2007;42:620–8.CrossRefPubMed
25.
Zurück zum Zitat Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defences with intralipid. Lancet. 1980;2:819–20.CrossRefPubMed Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defences with intralipid. Lancet. 1980;2:819–20.CrossRefPubMed
26.
Zurück zum Zitat Härtel C, Schultz C, Herting E, Göpel W. Genetic association studies in VLBW infants exemplifying susceptibility to sepsis—recent findings and implications for future research. Acta Paediatr. 2007;96:158–65.CrossRefPubMed Härtel C, Schultz C, Herting E, Göpel W. Genetic association studies in VLBW infants exemplifying susceptibility to sepsis—recent findings and implications for future research. Acta Paediatr. 2007;96:158–65.CrossRefPubMed
27.
Zurück zum Zitat Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics. 2009;123:1314–9.CrossRefPubMed Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics. 2009;123:1314–9.CrossRefPubMed
28.
Zurück zum Zitat Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics. 2006;118:1811–8.CrossRefPubMed Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics. 2006;118:1811–8.CrossRefPubMed
29.
Zurück zum Zitat Lilien LD, Rosenfield RL, Baccaro MM, Pildes RS. Hyperglycemia in stressed small premature neonates. J Pediatr. 1979;94:454–9.CrossRefPubMed Lilien LD, Rosenfield RL, Baccaro MM, Pildes RS. Hyperglycemia in stressed small premature neonates. J Pediatr. 1979;94:454–9.CrossRefPubMed
30.
Zurück zum Zitat Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15:533–51.CrossRefPubMed Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15:533–51.CrossRefPubMed
31.
Zurück zum Zitat Mizock BA. Blood glucose management during critical illness. Rev Endocr Metab Disord. 2003;4:187–94.CrossRefPubMed Mizock BA. Blood glucose management during critical illness. Rev Endocr Metab Disord. 2003;4:187–94.CrossRefPubMed
32.
Zurück zum Zitat Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol. 1997;83:1566–74.PubMed Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol. 1997;83:1566–74.PubMed
33.
Zurück zum Zitat Reinhold D, Ansorge S, Schleicher ED. Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res. 1996;28:267–70.CrossRefPubMed Reinhold D, Ansorge S, Schleicher ED. Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res. 1996;28:267–70.CrossRefPubMed
34.
Zurück zum Zitat Gregory R, McElveen J, Tattersall RB, Todd I. The effects of 3-hydroxybutyrate and glucose on human T cell responses to Candida albicans. FEMS Immunol Med Microbiol. 1993;7:315–20.CrossRefPubMed Gregory R, McElveen J, Tattersall RB, Todd I. The effects of 3-hydroxybutyrate and glucose on human T cell responses to Candida albicans. FEMS Immunol Med Microbiol. 1993;7:315–20.CrossRefPubMed
35.
Zurück zum Zitat Matsukawa A, Hogaboam CM, Lukacs NW, Kunkel SL. Chemokines and innate immunity. Rev Immunogenet. 2000;2:339–58.PubMed Matsukawa A, Hogaboam CM, Lukacs NW, Kunkel SL. Chemokines and innate immunity. Rev Immunogenet. 2000;2:339–58.PubMed
36.
Zurück zum Zitat Yaqoob P. Monosaturated fatty acids in parenteral nutrition, evaluation of risks and benefits. Br J Nutr. 2005;94:867–8.CrossRefPubMed Yaqoob P. Monosaturated fatty acids in parenteral nutrition, evaluation of risks and benefits. Br J Nutr. 2005;94:867–8.CrossRefPubMed
Metadaten
Titel
The modulatory effect of lipids and glucose on the neonatal immune response induced by Staphylococcus epidermidis
verfasst von
Berit Haase
Kirstin Faust
Mathias Heidemann
Tasja Scholz
Martin Demmert
Birte Tröger
Alexander Herz
Christoph Härtel
Publikationsdatum
01.03.2011
Verlag
SP Birkhäuser Verlag Basel
Erschienen in
Inflammation Research / Ausgabe 3/2011
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-010-0258-5

Weitere Artikel der Ausgabe 3/2011

Inflammation Research 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.